Literature DB >> 28366647

Adjustable Bilateral Superior Oblique Tendon Advancement for Bilateral Fourth Nerve Palsy.

Bashar M Bata1, David A Leske1, Jonathan M Holmes2.   

Abstract

PURPOSE: Bilateral fourth nerve palsy may be symmetric or asymmetric with combined vertical and excylotropic deviations and so there may be an advantage to independent adjustment of vertical and torsional components. We report a surgical technique that allows such independent adjustment.
DESIGN: Retrospective interventional case series.
METHODS: Fifteen patients, aged 17-73 years, underwent adjustable bilateral superior oblique tendon advancements for bilateral fourth nerve palsy: 11 symmetric (≤2 prism diopters [pd] hyperdeviation in straight-ahead gaze) and 4 asymmetric. Motor alignment was assessed with double Maddox rods and prism and alternate cover tests preoperatively, pre- and postadjustment, and 6 weeks postoperatively.
RESULTS: Preoperative torsion ranged from 7 to 30 degrees excyclotropia (mean 17 ± 7 degrees) and hyperdeviation from 0 to 10 pd. Preadjustment torsion ranged from 5 degrees excyclotropia to 40 degrees incyclotropia, and hyperdeviation from 0 to 8 pd. Twelve of the 15 patients (80%) were adjusted to a target of 0 pd hyperphoria and 10 degrees incyclotropia (actual mean 9 degrees incyclotropia, range 2-13 degrees incyclotropia). At 6 weeks postoperatively there was expected excyclodrift (to mean 4 degrees excyclotropia, range 0 degrees incyclotropia to 15 degrees excyclotropia), but 13 (87%) had 5 degrees or less excyclotropia and 14 (93%) had 2 pd or less hyperdeviation. Mean torsional correction from preoperative to preadjustment was 31 ± 14 degrees (P < .0001), and from preoperative to 6 weeks was 13 ± 6 degrees (P < .0001).
CONCLUSIONS: Adjustable bilateral superior oblique tendon advancement allows independent control of torsional and vertical components of the deviation, and therefore may be useful in cases of bilateral superior oblique palsy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28366647      PMCID: PMC5510608          DOI: 10.1016/j.ajo.2017.03.028

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  The long-term torsion effect of the adjustable Harada-Ito procedure.

Authors:  Julie K Nishimura; Arthur L Rosenbaum
Journal:  J AAPOS       Date:  2002-06       Impact factor: 1.220

2.  New strabismus surgical techniques.

Authors:  Irene H Ludwig; Robert A Clark; David R Stager
Journal:  J AAPOS       Date:  2013-02       Impact factor: 1.220

3.  New methods for quantifying diplopia.

Authors:  Jonathan M Holmes; David A Leske; Mark J Kupersmith
Journal:  Ophthalmology       Date:  2005-09-26       Impact factor: 12.079

4.  Exaggerated traction test for the oblique muscles.

Authors:  D L Guyton
Journal:  Ophthalmology       Date:  1981-10       Impact factor: 12.079

5.  The adjustable Harada-Ito procedure.

Authors:  H S Metz; H Lerner
Journal:  Arch Ophthalmol       Date:  1981-04

6.  Quantitative Intraoperative Torsional Forced Duction Test.

Authors:  Jae Ho Jung; Jonathan M Holmes
Journal:  Ophthalmology       Date:  2015-06-27       Impact factor: 12.079

7.  Postoperative adjustable surgery of the superior oblique tendon.

Authors:  Nitza Goldenberg-Cohen; Kristina Tarczy-Hornoch; David F Klink; David L Guyton
Journal:  Strabismus       Date:  2005-03

8.  Superior rectus transposition and medial rectus recession for Duane syndrome and sixth nerve palsy.

Authors:  Reshma A Mehendale; Linda R Dagi; Carolyn Wu; Danielle Ledoux; Suzanne Johnston; David G Hunter
Journal:  Arch Ophthalmol       Date:  2012-02

9.  Intraoperative monitoring of torsion to prevent vertical deviations during augmented vertical rectus transposition surgery.

Authors:  Jonathan M Holmes; Sarah R Hatt; David A Leske
Journal:  J AAPOS       Date:  2012-04       Impact factor: 1.220

10.  Quantifying diplopia with a questionnaire.

Authors:  Jonathan M Holmes; Laura Liebermann; Sarah R Hatt; Stephen J Smith; David A Leske
Journal:  Ophthalmology       Date:  2013-03-24       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.